MBE
TMO icon

Michael B. Elefante’s Thermo Fisher Scientific TMO Stock Holding History

Michael B. Elefante’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-800
Closed -$89K – 144
2013
Q4 		$89K Buy
+800
New +$79.5K 0.04% 110

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $32.7B AUM 17.15% 1-Year Est. Return

Michael B. Elefante's TMO Position: Q1 2014 in Review

Michael B. Elefante sold out of Thermo Fisher Scientific (TMO) in Q1 2014, closing a stake of 800 shares — an estimated $89K sold.

Michael B. Elefante first reported a position in TMO in Q4 2013 and held it in 1 quarter. The position peaked at $89K in Q4 2013. 915 funds tracked by Wall St. Rank hold TMO as of Q1 2014.

  • Michael B. Elefante reported no remaining Thermo Fisher Scientific position as of Q1 2014 after selling out during the quarter.
  • Michael B. Elefante sold 800 Thermo Fisher Scientific shares in Q1 2014, an estimated $89K.
  • Michael B. Elefante first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 1 quarter.
  • Michael B. Elefante's Thermo Fisher Scientific position peaked at $89K in Q4 2013.
  • 915 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2014.

Based on Michael B. Elefante's 13F filing for Q1 2014, filed 29 May 2014.